Prospective Biospecimen Collection: A Cornerstone for Personalized Medicine
The evolution of personalized healthcare is significantly transforming disease diagnosis, treatment, and management by focusing on therapies tailored to individual genetic, molecular, and clinical profiles. Central to this transformation is the prospective biospecimen collection, which provides researchers with fresh, clinically relevant human samples collected according to predefined study protocols. This approach is crucial for pharmaceutical companies, biotechnology firms, and academic institutions, as it supports biomarker discovery, companion diagnostic development, and precision medicine. Unlike retrospective collections, prospective collections are performed specifically for research projects, allowing researchers to define patient eligibility criteria, sample collection timelines, and processing requirements before recruitment begins. This customization improves specimen quality and ensures that collected samples meet exact scientific objectives. 
